Also trades as: RADL3.SA (SAO) · $vol 40M

$3.76

+0.41 (+12.41%)

Weekly Expected Move ±8.4%

$3 $3 $4 $4 $4

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 44 · $6.6B mcap · 882M float · 0.015% daily turnover · Short 5% of daily vol

Revenue

$43.4B +11.6% ▲

5Y CAGR: +16.7%

Gross Profit

$10.7B -7.0% ▼

5Y CAGR: +12.8%

Operating Income

$2.6B +9.2% ▲

5Y CAGR: +24.8%

Net Income

$1.3B +6.2% ▲

5Y CAGR: +21.3%

EPS (Diluted)

$0.77 +6.9% ▲

5Y CAGR: +22.4%

EBITDA

$4.6B +45.2% ▲

5Y CAGR: +17.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$24.1B	$29.1B	$34.0B	$38.9B	$43.4B
YoY Growth	+20.2%	+20.5%	+16.9%	+14.4%	+11.6%
Cost of Revenue	$16.9B	$20.3B	$23.8B	$27.3B	$32.6B
Gross Profit	$7.2B	$8.8B	$10.2B	$11.5B	$10.7B
Gross Margin	29.9%	30.3%	30.0%	29.7%	24.7%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$5.9B	$7.1B	$8.2B	$9.2B	$8.1B
Operating Expenses	$5.8B	$7.0B	$8.1B	$9.2B	$8.2B
Operating Income	$1.2B	$1.5B	$2.1B	$2.4B	$2.6B
Operating Margin	5.1%	5.1%	6.1%	6.1%	6.0%
Interest Expense	$228M	$293M	$738M	$813M	$1.1B
Income Before Tax	$987M	$1.2B	$1.2B	$1.4B	$1.4B
Tax Expense	$223M	$178M	$130M	$207M	$145M
Net Income	$752M	$996M	$1.1B	$1.2B	$1.3B
Net Margin	3.1%	3.4%	3.1%	3.1%	2.9%
EPS (Diluted)	$0.44	$0.58	$0.62	$0.72	$0.77
EBITDA	$2.6B	$2.5B	$2.8B	$3.1B	$4.6B
Shares Outstanding	1.72B	1.72B	1.70B	1.65B	1.66B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$10.0B	$10.1B	$10.1B	$10.8B	$11.3B	$12.3B	$10.6B	$11.3B
Cost of Revenue	$7.0B	$7.1B	$7.2B	$7.6B	$8.5B	$9.2B	$7.2B	$8.1B
Gross Profit	$3.0B	$3.0B	$2.9B	$3.2B	$2.8B	$3.1B	$3.4B	$3.2B
Gross Margin	29.7%	29.6%	28.7%	29.6%	24.9%	25.1%	32.1%	28.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$2.3B	$2.5B	$2.4B	$2.5B	$2.1B	$2.3B	$2.7B	$2.9B
Operating Expenses	$2.3B	$2.5B	$2.4B	$2.5B	$2.1B	$2.4B	$2.7B	$2.4B
Operating Income	$679M	$531M	$485M	$717M	$746M	$682M	$652M	$885M
Operating Margin	6.8%	5.3%	4.8%	6.6%	6.6%	5.5%	6.2%	7.8%
Interest Expense	$201M	$214M	$217M	$279M	$273M	$304M	$299M	$287M
Income Before Tax	$441M	$279M	$200M	$400M	$545M	$308M	$127M	$542M
Tax Expense	$102M	-$69M	$35M	$17M	$83M	$13M	-$20M	$117M
Net Income	$335M	$348M	$164M	$374M	$454M	$310M	$159M	$434M
Net Margin	3.4%	3.5%	1.6%	3.5%	4.0%	2.5%	1.5%	3.8%
EPS (Diluted)	$0.20	$0.21	$0.10	$0.23	$0.27	$0.18	$0.09	$0.25
EBITDA	$1.1B	$11M	$915M	$1.2B	$1.3B	$1.2B	$988M	$1.4B
Shares Outstanding	1.66B	1.66B	1.65B	1.66B	1.71B	1.75B	1.69B	1.75B

RADLY OTC